Principal Financial Group Inc. Investment in GeneDx Holdings Corp. (NASDAQ:WGS) Reaches $604,000

Principal Financial Group Inc. recently made a bold move by acquiring 14,240 shares of GeneDx Holdings Corp. (NASDAQ:WGS) during the third quarter. The purchase totaled approximately $604,000, giving Principal Financial Group Inc. ownership of about 0.05% of GeneDx at the time of their SEC filing.

This investment follows similar moves by other hedge funds, showing a growing interest in GeneDx. Vanguard Group Inc. expanded its position by 4.2% in the first quarter, Driehaus Capital Management LLC and Assenagon Asset Management S.A. both acquired new stakes in the second quarter, and Millennium Management LLC and Divisadero Street Capital Management LP also increased their holdings in GeneDx during the second quarter. In total, institutional investors and hedge funds now own 61.72% of GeneDx.

Analysts have weighed in on GeneDx, with several recommending a “buy” rating. BTIG Research, Craig Hallum, TD Cowen, Wells Fargo & Company, and The Goldman Sachs Group have recently raised their price targets for the stock, reflecting a positive outlook on GeneDx’s future prospects.

GeneDx’s stock price has been on the rise, with a 9.2% increase recently. Trading at $78.71 per share, the company’s market capitalization is $2.16 billion, with a 1-year high of $89.11. GeneDx has seen significant growth in revenue, reporting $76.90 million in the last quarter, a 44.3% increase from the previous year.

Notable insider activity includes a major shareholder from the School Of Medicine At Mo Icahn selling 865,800 shares, and Director Jason Ryan selling 31,510 shares recently. These transactions indicate confidence in GeneDx’s future performance.

Overall, GeneDx Holdings Corp. is showing strong potential for growth, with positive analyst ratings, significant insider activity, and a rising stock price contributing to its promising outlook in the market.